in silico methods in fragment-based drug design — a Protein Kinase B case study

webinar

Wed, 28 Jan 2015, 19:00 CET (Berlin)

Dr. Alastair Donald, BioSolveIT GmbH, St. Augustin, Germany

in silico methods in fragment-based drug design — a Protein Kinase B case study

Computational tools are invaluable in the process of identifying high-quality fragment hits. In this one hour BioSolveIT webinar you will learn how to fast-track your fragment hit discovery using our cutting edge in silico solutions using Protein Kinase B as an example.

By the end you will appreciate how our suite of SBDD tools can enrich your work life, enhance your productivity and assist in the identification of potent, selective and synthetically accessible lead-like molecules.

So, if you are interested in

  • enriching your screening collection with potent and selective fragments
  • intelligently selecting which commercially available analogs to purchase
  • deciding which analogs to prioritize for synthesis
  • saving time and money by focusing on the most promising ideas

watch the video live recording below.

Current news

Tool of the Month - FlexS
June 30, 2026 10:59 CEST
This Summer, You Wear Molecule Alignment This July, see Similarity in 3D with FlexS as BioSolveIT’s Tool of the Month. In ligand-based drug discovery, the most interesting molecules are not always the ones that look similar on paper. Sometimes, the true connection only becomes visible in 3D. FlexS helps uncover...
Read on
category
Events
Important News: Free Access to SeeSAR & Chemical Space DockingĀ®
June 29, 2026 15:39 CEST
BioSolveIT has turned 25, and we want to celebrate properly! As part of our Tool-of-the-Month series, we are making SeeSAR, including Chemical Space DockingĀ® (C-S-D), available completely free of charge for 2.5 months. From September 1 to November 15, 2026, users can explore and test all features of SeeSAR and...
Read on
AuriVerse by Aurigene - Access now with our tools
June 15, 2026 11:00 CEST
We are happy to integrate AuriVerse to our portfolio of Chemical Spaces, created in collaboration between Aurigene Pharmaceutical Services and BioSolveIT. AuriVerse marks our first Chemical Space partnership with a company based in India, extending the portfolio into a new region of expert make-on-demand chemistry. AuriVerse brings a precision-engineered universe...
Read on